Navigation Links
MFM researcher earns $3.7M NIH grant to study preterm birth
Date:10/6/2010

Fetal growth is used as a marker of health and well-being in unborn babies as well as children. But, the tools that are currently available to differentiate between a small, healthy fetus and a fetus that is small due to pathologic causes have significant limitations. What if they were improved? Would it save the health care system resources spent monitoring women who might need medical intervention because their fetuses might just be small and healthy? Would it help some women avoid the anxiety such intervention brings?

Those are the questions being addressed by Edward Chien, MD, a physician in the Division of Maternal-Fetal Medicine at Women & Infants Hospital of Rhode Island and an assistant professor of obstetrics and gynecology at The Warren Alpert Medical School of Brown University. Dr. Chien recently joined the "The National Standard for Normal Fetal Growth" study designed to develop more accurate algorithms for tracking fetal development and predicting which fetuses are abnormally small and unhealthy. He will serve as the primary investigator on this $3.7-million, two-year grant from the National Institutes of Health (NIH).

Beginning in the next few months, his team will recruit up to 700 pregnant women with low risk for prenatal complications, as well as women pregnant with twins. Because the study will evaluate growth patterns by race and ethnicity, they will recruit specific numbers of Caucasian, Asian, African American and Hispanic women. They will also recruit a specific number of obese women to study the effect of maternal obesity on fetal health and growth.

About 10% of babies born in this country are small. Like children or adults, not all of these babies are unhealthy. This study seeks to identify those individuals who are small and healthy from those who are unhealthy.

"Growth is a longitudinal measure. We hope to develop an algorithm that will look at fetal size, fetal growth and changes in the body during
'/>"/>

Contact: Susan McDonald
slmcdonald@wihri.org
401-681-2816
Women & Infants Hospital
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Blood test could diagnose Alzheimers disease, UT Southwestern researchers find
2. Better cholesterol drugs may follow Saint Louis University researchers breakthrough
3. Mayo researchers find biomarkers for personalizing radiation cancer treatment
4. Insurance, Race and Poverty Affect Cancer Care, Researchers Report
5. Johns Hopkins researchers turn off severe food allergies in mice
6. UTHealth researchers awarded $15 million for teen pregnancy prevention
7. Researchers discover genetic changes that make some forms of brain cancer more aggressive
8. Researchers find no difference in drugs for macular degeneration
9. Researchers advance biosynthesis of potent anti-cancer drug Taxol
10. Researchers engineer microbes for low-cost production of anti-cancer drug, Taxol
11. Researchers at the University of Granada associate trigger points with shoulder injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... 2015 , ... Healthpointe ’s Cosmetic Laser Institute in Anaheim is now ... and reduces the appearance of fine lines and wrinkles. , According to the Allergan ... add volume to your cheek area to correct age-related volume loss in adults over ...
(Date:7/28/2015)... ... 28, 2015 , ... On July 16th NPR reported needle exchange ... proposed bills and laws revolving the implementation of a small pilot program in Miami-Dade ... are continuing to hand out clean needles to drug users who are addicted to ...
(Date:7/28/2015)... PAUL, Minn. (PRWEB) , ... July 28, 2015 ... ... workflow company Kinetic Data announced that Schneider Electric has completed its upgrade ... Electric is a global organization with more than 170,000 employees in 134 countries ...
(Date:7/28/2015)... ... July 28, 2015 , ... Safeguard ... authorized the Company, from time to time and depending on market conditions, to ... to $25 million. Repurchases will be made in open market or privately negotiated ...
(Date:7/28/2015)... ... , ... Women fear developing Alzheimer's disease more than having a heart attack ... are treatable, but there is little an individual can do to arrest the progress ... clinical trial, reports the July 2015 Harvard Women's Health Watch . , "There ...
Breaking Medicine News(10 mins):Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 2Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 3Health News:Needle Exchange Programs Are Delayed in Legislation, West Palm Beach Drug Rehab Comments 2Health News:Needle Exchange Programs Are Delayed in Legislation, West Palm Beach Drug Rehab Comments 3Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 2Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 3Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 4Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 2Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 3Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 3
... (OTC,Bulletin Board: SNKTY), a Life Sciences company engaged ... of healthy aging, today announced,that effective with the ... for Pyratine-6(TM), all promotion, sales and distribution of,Pyratine-6(TM) ... Company., Phil Rose, Senetek,s Chief Operating Officer ...
... 1 UTC Power, a United,Technologies Corp. (NYSE: ... Hospital in California,s Napa Valley with its new, next-generation,fuel ... in full,production in the summer of 2009., St. ... of Adventist Health, a not-for-profit health care system operating ...
... RGEN ) announced today that Dr. Alfred L. Goldberg, ... Goldberg is currently a Professor of,Cell Biology at Harvard ... for elucidating the structure and function of the proteasome,which ... in,cells. In addition, he has made major contributions to ...
... increase as women go through menopause according to ... earlier than planned also increases through late perimenopause ... is published in the July 1 issue of ... especially problems staying asleep, are relatively prevalent concerns ...
... direct marketing promotional products company, is tapped in to a network ... products. , ... Lewiston, ME (PRWEB) July 1, 2008 ... on its Web site, Crestline Custom Imprinted Products, a direct marketing ...
... as new surgical procedures are,breaking ground daily in ... breaking ground for patients. LipoVance.com,( http://www.LipoVance.com ) is ... it is offering an unprecedented $800 coupon,toward liposuction ... "In today,s troubled economy," said Kevin Gaines ...
Cached Medicine News:Health News:Senetek Announces Plan for Promotion, Sales and Distribution of Pyratine-6(TM) 2Health News:St. Helena's Hospital Orders New Model 400kW Fuel Cell From UTC Power 2Health News:Repligen Elects Alfred L. Goldberg, Ph.D. to the Board of Directors 2Health News:Repligen Elects Alfred L. Goldberg, Ph.D. to the Board of Directors 3Health News:Sleep problems associated with menopause vary among ethnic groups 2Health News:Crestline Has Access to Hundreds of Thousands of Items 2Health News:The Shape of Things to Come: Website Gives the Lowdown on Liposuction, Pioneers the Field by Offering Consumers $800 Coupons Toward Procedures 2
(Date:7/28/2015)... 28, 2015 Voalte, the leader in ... in purpose-built wireless communications, today announced that Bay ... 104-bed acute-care facility in Webster, Texas ... One™ solution on Spectralink PIVOT™ purpose-built smartphones for ... Voalte a member of its AIMS Partner Program ...
(Date:7/28/2015)... July 21, 2015 Research and Markets ... the "Pharmaceutical Industry in China to 2020: ... Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, ... offering. This report tackles not ... China but also home grown companies ...
(Date:7/28/2015)... YORK , July 28, 2015 /PRNewswire/ ... a new research report with market overview, ... share, forecast, porter analysis, recent developments, competitive ... Global Industry Insight: Human Insulin Market ...      (Logo: http://photos.prnewswire.com/prnh/20150727/756778) Explore ...
Breaking Medicine Technology:Bay Area Regional Medical Center Is First to Use Spectralink PIVOT with Voalte One for Caregiver Communication 2Bay Area Regional Medical Center Is First to Use Spectralink PIVOT with Voalte One for Caregiver Communication 3Pharmaceutical Industry in China to 2020: Market to Increase Dramatically to $200 Billion 2Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 2Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 3Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 4Global Human Insulin Market (Size of $24 billion in 2014) to Witness 13% CAGR During 2015 - 2020 5
... -- China Medical Technologies, Inc. (the "Company") (Nasdaq: ... in-vitro diagnostic ("IVD") company, today announced that its ... ("GP Medical") and Beijing Yuande Bio-Medical Engineering Co., ... 415th, respectively, in the Deloitte Technology Fast 500 ...
... SUNNYVALE, Calif., Dec. 5, 2010 Pharmacyclics, Inc. (Nasdaq: ... Chronic Lymphocytic Leukemia (CLL) presentations at the American Society ... PCI-32765.  Two presentations report preclinical data, and one presentation ... patients with CLL or Small Lymphocytic Lymphoma (SLL) treated ...
Cached Medicine Technology:China Medical Technologies Announces its Subsidiaries, GP Medical and Beijing Yuande, Ranked 12th and 415th, respectively, in Deloitte Technology Fast 500 Asia Pacific 2010 Program 2Pharmacyclics Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765 2Pharmacyclics Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765 3Pharmacyclics Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765 4Pharmacyclics Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765 5Pharmacyclics Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765 6Pharmacyclics Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765 7
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: